Gilead Sciences (60)

Browse by Contract Category

Contracts

Form of non-employee director restricted stock unit (Filed With SEC on August 8, 2022)
Form of global employee restricted stock unit agreement under 2022 Equity Incentive Plan (4 year vest) (for certain grants commencing in 2022) (Filed With SEC on August 8, 2022)
Agreement and Plan of Merger, dated September 13, 2020, among Immunomedics, Inc., Gilead Sciences, Inc. and Maui Merger Sub, Inc (Filed With SEC on September 14, 2020)
Letter Agreement between Registrant and Johanna Mercier, dated May 4, 2020 (Filed With SEC on August 6, 2020)
Amended and Restated EVG License Agreement between Japan Tobacco Inc., and Registrant, dated November 29, 2018 (Filed With SEC on February 26, 2019)
Form of non-employee director stock option agreement under 2022 Equity Incentive Plan (for grants commencing in 2022) (Filed With SEC on August 8, 2022)
Form of global employee stock option agreement under 2022 Equity Incentive Plan (4 year vest) (for certain grants commencing in 2022) (Filed With SEC on August 8, 2022)
Gilead Sciences, Inc. 2022 Equity Incentive Plan (Filed With SEC on May 5, 2022)
Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2022) (Filed With SEC on May 4, 2022)
Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 202 (Filed With SEC on May 4, 2022)
Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2022) (Filed With SEC on May 4, 2022)
Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2022) (Filed With SEC on May 4, 2022)
Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2021) (Filed With SEC on May 6, 2021)
Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2021) (Filed With SEC on May 6, 2021)
Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2021) (Filed With SEC on May 6, 2021)
Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2021) (Filed With SEC on May 6, 2021)
Amendment No. 1 to Gilead Sciences, Inc. 2004 Equity Incentive Plan, amended and restated May 10, 2017 (Filed With SEC on February 25, 2021)
Eighth Supplemental Indenture, dated as of September 30, 2020, between the Company and Wells Fargo Bank, National Association, as Trustee (Filed With SEC on September 30, 2020)
Underwriting Agreement, dated September 23, 2020, among the Company and Barclays Capital Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters... (Filed With SEC on September 29, 2020)
Gilead Sciences, Inc. Severance Plan, amended and restated May 5, 2020 (Filed With SEC on August 6, 2020)
Gilead Sciences, Inc. 2018 Equity Incentive Plan, amended and restated April 7, 2020 (Filed With SEC on August 6, 2020)
Form of non-employee director restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on August 6, 2020)
Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on August 6, 2020)
Gilead Sciences, Inc. Retention Program for Senior Vice Presidents and Executive Vice Presidents (Filed With SEC on May 6, 2020)
Global restricted stock unit issuance agreement for Merdad Parsey (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)
Global stock option agreement for Merdad Parsey (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)
Offer Letter between Registrant and Merdad Parsey, dated September 29, 2019 (Filed With SEC on May 6, 2020)
Global restricted stock unit issuance agreement for Johanna Mercier (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)
Restricted stock unit issuance agreement for Johanna Mercier (for Performance Objectives in 2019-2020) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)
Global stock option agreement for Johanna Mercier (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on May 6, 2020)
Gilead Sciences, Inc. Corporate Annual Incentive Plan, amended and restated January 1, 2020 (Filed With SEC on May 6, 2020)
Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2020) (Filed With SEC on May 6, 2020)
Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (3 year vest) (for grants commencing in 2020) (Filed With SEC on May 6, 2020)
Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on May 6, 2020)
Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2020) (Filed With SEC on May 6, 2020)
Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2020) (Filed With SEC on May 6, 2020)
Agreement and Plan of Merger, dated March 1, 2020, among Forty Seven, Inc., Gilead Sciences, Inc. and Toro Merger Sub, Inc (Filed With SEC on March 2, 2020)
Severance and General Release Agreement between Registration and Laura Hamill, dated June 6, 2019 (Filed With SEC on February 25, 2020)
Offer Letter between Registrant and Laura Hamill, dated August 8, 2018 (Filed With SEC on February 25, 2020)
Description of Registrant's Securities (Filed With SEC on February 25, 2020)
Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2019) (Filed With SEC on November 5, 2019)
Form of global employee stock option agreement under 2004 Equity Incentive Plan (4 year vest) (for grants commencing in 2019) (Filed With SEC on November 5, 2019)
Form of global employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (3 year vest) (for grants commencing in 2019) (Filed With SEC on November 5, 2019)
Transition and Severance Agreement dated July 15, 2019 between Registrant and John McHutchison (Filed With SEC on November 5, 2019)
Transition and Severance Agreement dated July 15, 2019 between Registrant and Gregg Alton (Filed With SEC on November 5, 2019)
Gilead Sciences, Inc. Severance Plan, amended and restated July 24, 2019 (Filed With SEC on November 5, 2019)
Letter dated October 11, 2019 between Gilead Sciences, Inc. and Andrew Dickinson (Filed With SEC on October 15, 2019)
Gilead Sciences, Inc. 2005 Deferred Compensation Plan, as amended and restated April 19, 2016 (Filed With SEC on August 6, 2019)
Form of non-employee director stock option agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)
Form of performance share award agreement - TSR Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)
Form of performance share award agreement - Revenue Goals (U.S.) under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)
Form of employee restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)
Form of non-employee director restricted stock unit issuance agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)
Form of employee stock option agreement under 2004 Equity Incentive Plan (for grants commencing in 2019) (Filed With SEC on August 6, 2019)
Offer Letter dated May 21, 2019 between Registrant and Johanna Mercier (Filed With SEC on August 6, 2019)
Stock option agreement for Daniel ODay under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)
Performance share award agreement for Daniel ODay (for TSR Goals in 2019) under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)
Performance share award agreement for Daniel ODay (for Revenue Goals in 2019) under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)
Form of restricted stock unit issuance agreement for Daniel ODay (in 2019) under 2004 Equity Incentive Plan (Filed With SEC on August 6, 2019)
Master Agreement by and between Registrant, Gilead Sciences K.K. and Japan Tobacco Inc., dated November 29, 2018 (Filed With SEC on February 26, 2019)